Cart
sales@molnova.com
LY2880070
CAS No. 1375637-35-6
LY2880070( —— )
Catalog No. M23534 CAS No. 1375637-35-6
LY2880070 is a new checkpoint kinase 1 (CHK1) inhibitor for cancer therapy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 272 | In Stock |
|
| 10MG | 408 | In Stock |
|
| 25MG | 672 | In Stock |
|
| 50MG | 945 | In Stock |
|
| 100MG | 1278 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLY2880070
-
NoteResearch use only, not for human use.
-
Brief DescriptionLY2880070 is a new checkpoint kinase 1 (CHK1) inhibitor for cancer therapy.
-
DescriptionLY2880070 is a new checkpoint kinase 1 (CHK1) inhibitor for cancer therapy.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetChk
-
RecptorChk1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1375637-35-6
-
Formula Weight381.43
-
Molecular FormulaC19H23N7O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc(cc1)nc(OC)c1-c1cc(Nc2cncc(O[C@H]3CNCCC3)n2)n[nH]1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CCT241533 hydrochlor...
A potent and selective ATP-competitive inhibitor of CHK2 K5777:N5777with IC50 of 3 nM; shows good selectivity for CHK2 against CHK1 (IC50=180 nM) .
-
Tuvusertib
Tuvusertib (M1774) is an orally available ataxia telangiectasia and Rad3-related (ATR) kinase inhibitor (Ki< 1 μΜ) with selective and potentially antitumor activity.
-
GDC-0425
A potent, selective and orally active Chk1 inhibitor; enhances gemcitabine efficacy in tumor xenograft models.
